Hasil Pencarian  ::  Simpan CSV :: Kembali

"The sequencing of the human genome opened a new world of biomarkers. Is it possible to tell by a person's genetic signature how they would respond to a particular drug? his is the dream of "personalized medicine". At the moment as many as half of all drugs do not work for the people who take them. Such pharmacogenomics could also reduce the size and cost of clinical tests by allowing pharma firms to select the most suitable patients. But the reality is rather different. The difficulty lies in proving that they reliably correlete with clinical outcome. Companies that had placed their faith in genomics are now caught in a dilemma: to produce information only or new drugs. As the cost of gene sequencing has fallen, firms have rushed to offer genetic tests directly to consumers, often raising grand expectations. There now seems to be a backlash. Doctors have complained about being bypassed. Most generic tests directly do not provide conclusive evidence of this risk of disease Some academics also remain deeply skeptical about genomics being used in medicine. In addition , personalised medicine would be economic folly for firms who would need to develop a special pill for every patient. Traditionally firms sold conventional one - size - all drugs. Perhaps a better way would be mass customization."

"This book, with the focus on the most advanced cutting-edge breakthroughs, covers all the essential aspects of the field of molecular farming in plants: from expression technologies to downstream processing, from products to safety issues, and from current advances and holdups to future developments. "

"Salah satu alternatif untuk mendapatkan peforma yang lebih bagus dalam proses dari segi teknis dan ekonomi adalah intensifikasi proses pada proses produksi biodiesel menggunakan distilasi reaktif. Penelitian ini melakukan komparasi dua skenario produksi biodiesel dari e-metanol (metanol dari hidrogenasi CO2 dengan CO2 berasal dari CO2 capture dan hidrogen berasal dari elektrolisis dengan PEM electrolyzer) tanpa intensifikasi proses (S1) dan produksi biodiesel dari e-metanol dengan intensifikasi proses menggunakan distilasi reaktif (S2).  Hasil penelitian didapatkan bahwa produksi biodiesel dengan distilasi reaktif menunjukan peforma yang lebih baik dari segi teknis maupun ekonomi. Dari segi teknis menunjukan, konversi reaktan yang didapatkan pada distilasi reaktif mencapai 95,22%. Selain itu kebutuhan ratio mol asam lemak dan metanol dari S2 (1:8) lebih sedikit dibanding dengan S1 (1:15). Kemudian dari analisis energi, juga didapatkan efisiensi dan produktifitas energi dari S2 (32% dan 7,788 kg/MJ) lebih tinggi dibanding dengan S1 (28% dan 3,788 kg/MJ). Lalu dari analisis emisi CO2, S2 lebih rendah emisi 68,2% dibanding S1. Terakhir untuk analisis ekonomi, kedua skenario menghasilkan nilai net present value yang negatif sehingga proyek tidak layak untuk dijalankan karena biaya investasi dari produksi hidrogen dengan sistem PEM+PV+baterai yang masih mahal namun nilai net present value negatif dari S2 masih 60,41% lebih rendah dibanding S1

---

One alternative to get better performance in the process from a technical and economic point of view is process intensification in the biodiesel production process using reactive distillation. This research compares two scenarios of biodiesel production from e-methanol (methanol from CO2 hydrogenation with CO2 comes from CO2 capture and hydrogen comes from electrolysis with PEM electrolyzer) without process intensification (S1) and biodiesel production from e-methanol with process intensification using distillation. reactive (S2). The results showed that biodiesel production by reactive distillation showed better performance from a technical and economic standpoint. From a technical point of view, the conversion of reactants obtained in reactive distillation reaches 95.22%. In addition, the need for the mole ratio of fatty acids and methanol from S2 (1:8) is less than that of S1 (1:15). Then from the energy analysis, it was also found that the energy efficiency and productivity of S2 (32% and 7.788 kg/MJ) were higher than those of S1 (28% and 3.788 kg/MJ). Then from the analysis of CO2 emissions, S2 has 68.2% lower emissions than S1. Finally, for economic analysis, both scenarios produce a negative net present value, so the project is not feasible to run because the investment costs of hydrogen production with the PEM+PV+battery system are still expensive, but the negative net present value of S2 is still 60.41% more lower than S1."